Physical Activity Behavioral Intervention in Obese Endometrial Cancer

Status Completed

Clinical Trial Summary

This randomized clinical trial studies a physical activity behavioral intervention in obese endometrial cancer survivors. Learning about physical activity behavior while participating in a fitness class may help increase physical activity and improve the quality of life of obese endometrial cancer survivors.

Clinical Trial Description

PRIMARY OBJECTIVES:

I. To determine the effect of a 12-week behavior/exercise intervention on moderate-vigorous physical activity (> 150 minutes) among ethnically diverse endometrial cancer survivors.

SECONDARY OBJECTIVES:

I. To determine the effects of a 12-week behavior/exercise intervention on body composition among ethnically diverse endometrial cancer survivors.

TERTIARY OBJECTIVES:

I. To determine the effects of a 12-week behavior/exercise intervention for ethnically diverse endometrial cancer survivors on physical function and quality-of-life.

II. To determine the most important behavioral variables for predicting physical activity adherence.

III. To determine the most significant facilitators and barriers to adherence during the 12-week intervention.

IV. To compare the thematic differences between high-adherence and low-adherence participants and qualitatively assess the strengths and weaknesses of the 12-week intervention.

OUTLINE: Participants are randomized to 1 of 2 groups

GROUP I: Participants partake in 30 minutes of group discussions regarding physical activity behavior followed by 60 minutes of moderate-intensity exercise comprised of 5 minutes warm-up, 25 minutes cardiovascular training, 20 minutes of resistance training exercises using body weight and exercise band, and 10 minutes of cool-down and stretching once weekly for 12 weeks. Participants also complete a brisk walk for 90 minutes per week outside of class for 12 weeks.

GROUP II: Participants receive a handout indicating the importance of physical activity and improved nutrition for health outcomes. After 12 weeks, patients are invited to participate in the physical behavior intervention as in Group I.

After completion of study, participants are followed up at 12 weeks. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02575872
Study type	Interventional
Source	Albert Einstein College of Medicine
Contact
Status	Completed
Phase	N/A
Start date	October 2013
Completion date	June 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01208467` - Prognostic Biomarkers in Patients With Endometrial Cancer	N/A
Completed	`NCT01522820` - Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors	Phase 1
Active, not recruiting	`NCT00956670` - Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer	N/A
Completed	`NCT00897442` - Collecting Tumor Samples From Patients With Gynecological Tumors	N/A
Completed	`NCT01098630` - Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
Recruiting	`NCT03422198` - Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer	Phase 3
Not yet recruiting	`NCT01344837` - Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer	N/A
Not yet recruiting	`NCT01199250` - Biomarkers in Samples From Patients With Endometrial Cancer	N/A
Not yet recruiting	`NCT01198171` - Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer	N/A
Terminated	`NCT01041027` - Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer	Phase 2
Terminated	`NCT00577317` - Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer	Phase 3
Completed	`NCT02342730` - Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical Hyperplasia	N/A
Completed	`NCT03198286` - Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors	N/A
Completed	`NCT00002706` - Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Physical Activity Behavioral Intervention in Obese Endometrial Cancer Survivors

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms